Xeris Biopharma Holdings, Inc.
Stable formulations for parenteral injection of peptide drugs
Last updated:
Abstract:
Stable formulations for parenteral injection of peptide drugs and methods of using such stable formulations are provided. In particular, the present invention provides stable formulations for parenteral injection of glucagon and methods of using such glucagon formulations to treat hypoglycemia, especially severe hypoglycemia in emergency situations.
Status:
Grant
Type:
Utility
Filling date:
22 Mar 2016
Issue date:
27 Apr 2021